Nasal Congestion Global Clinical Trials Review, Q1, 2011

Date: January 1, 2011
Pages: 38
Price:
US$ 1,000.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: N259604B74DEN
Leaflet:

Download PDF Leaflet

Nasal Congestion Global Clinical Trials Review, Q1, 2011
Nasal Congestion Global Clinical Trials Review, Q1, 2011

Summary

GlobalData's clinical trial report, 'Nasal Congestion Global Clinical Trials Review, Q1, 2011' provides data on the Nasal Congestion clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Nasal Congestion. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope
  • Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status and trial success rate
  • Review of key discontinued trials (suspended, withdrawn and terminated)
  • Overview of the enrollment pattern by phase for the past decade
  • Number of clinical trials segmented by key drugs
  • Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
  • Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute, and others

Reasons to buy
  • Understand the dynamics of a particular indication as a whole
  • Examine the performance of the trials in terms of their status, recruitment, success rates and others
  • Obtain discontinued trial information for trials across the globe
  • Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Introduction
Nasal Congestion
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Nasal Congestion
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Nasal Congestion Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
BioCryst Pharmaceuticals, Inc.
Clinical Trial Overview of BioCryst Pharmaceuticals, Inc.
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
Ache Laboratorios Farmaceuticos S/A
Clinical Trial Overview of Ache Laboratorios Farmaceuticos S/A
Aardvark Medical, LLC
Clinical Trial Overview of Aardvark Medical, LLC
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
The Department of Health
Clinical Trial Overview of The Department of Health
Tehran University of Medical Sciences
Clinical Trial Overview of Tehran University of Medical Sciences
Clayton Sleep Institute
Clinical Trial Overview of Clayton Sleep Institute
University of Athens
Clinical Trial Overview of University of Athens
Weill Cornell Medical College
Clinical Trial Overview of Weill Cornell Medical College
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source 37

LIST OF TABLES

Nasal Congestion Therapeutics Market, Global, Clinical Trials by Zone, 2011*
Nasal Congestion Therapeutics Market, Global, Clinical Trials by Top Countries, 2011*
Nasal Congestion Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011*
Nasal Congestion Therapeutics Clinical Trials, Asia-Pacific ,Top Countries, 2011*
Nasal Congestion Therapeutics Clinical Trials, Europe, Top Five Countries, 2011*
Nasal Congestion Therapeutics Clinical Trials, North America, Top Countries, 2011*
Nasal Congestion Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2011*
Nasal Congestion Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2011*
Nasal Congestion Therapeutics Clinical Trials, BRIC Countries, 2011*
Nasal Congestion Therapeutics Market, Global, Clinical Trials by Phase, 2011*
Nasal Congestion Therapeutics Market, Global, Clinical Trials in Progress by Phase 2011*
Nasal Congestion Therapeutics Market, Global, Clinical Trials by Trial Status, 2011*
Nasal Congestion Therapeutics Market, Global, Terminated Clinical Trials, 2011*
Nasal Congestion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Nasal Congestion Therapeutics Clinical Trials, Global, Key Sponsors, 2011*
Nasal Congestion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011*
Nasal Congestion Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011*
Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by BioCryst Pharmaceuticals, Inc., 2011*
Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2011*
Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by Ache Laboratorios Farmaceuticos S/A, 2011*
Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by Aardvark Medical, LLC, 2011*
Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2011*
Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by The Department of Health, 2011*
Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2011*
Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by Clayton Sleep Institute, 2011*
Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Athens, 2011*
Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2011*
Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2011* 34

LIST OF FIGURES

Nasal Congestion Therapeutics Market, Global, Clinical Trials by Zone (%), 2011*
Nasal Congestion Therapeutics Market, Global, Clinical Trials by Top Countries, 2011*
Nasal Congestion Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011*
Nasal Congestion Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2011*
Nasal Congestion Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011*
Nasal Congestion Therapeutics Clinical Trials, North America, Top Countries (%), 2011*
Nasal Congestion Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2011*
Nasal Congestion Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2011*
Nasal Congestion Therapeutics Clinical Trials, BRIC Countries (%), 2011*
Nasal Congestion Therapeutics Market, Global, Clinical Trials by Phase (%), 2011*
Nasal Congestion Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2011*
Nasal Congestion Therapeutics Market, Global, Clinical Trials by Trial Status, 2011*
Nasal Congestion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Nasal Congestion Therapeutics Clinical Trials, Global, Key Sponsors, 2011*
Nasal Congestion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011*
Nasal Congestion Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011*
GlobalData Methodology 36
Nasal Polyps Global Clinical Trials Review, Q1, 2011 US$ 1,000.00 Jan, 2011 · 32 pages
Nasal Polyps Global Clinical Trials Review, H2, 2013 US$ 2,500.00 Sep, 2013 · 99 pages
Tonsillitis Global Clinical Trials Review, Q4, 2010 US$ 1,000.00 Dec, 2010 · 40 pages
Sarcomas Global Clinical Trials Review, Q4, 2010 US$ 1,000.00 Dec, 2010 · 83 pages

Ask Your Question

Nasal Congestion Global Clinical Trials Review, Q1, 2011
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: